However, we could not find any other high-level copy number changes such as concurrent 1q whole-arm gains or 16q whole-arm losses, which are hallmark genetic alterations of ER-positive/HER2-negative breast cancers (Figure 2, Supplementary Table 2–9). This evidence concerns the gene ERBB2 and breast cancer.